Related Experiment Videos
Pheochromocytoma: diagnosis and management update
William M Manger1, Graeme Eisenhofer
1New York University Medical Center and National Hypertension Association, 324 East 30th Street, New York, NY 10016, USA. nathypertension@aol
Current Hypertension Reports
|November 6, 2004
Summary
Pheochromocytoma, a rare neuroendocrine tumor, is dangerous if missed. Early detection via plasma metanephrines and imaging is crucial for timely surgical treatment, which is often curative.
Area of Science:
- Endocrinology
- Oncology
- Medical Diagnostics
Background:
- Pheochromocytoma is a rare neuroendocrine tumor secreting catecholamines.
- It can cause severe hypertension and mimic other diseases, leading to delayed diagnosis.
- Malignant, extra-adrenal, and familial forms have distinct clinical implications.
Purpose of the Study:
- To review the diagnostic and management strategies for pheochromocytoma.
- To highlight the importance of early recognition and appropriate treatment.
- To discuss the characteristics and prevalence of different pheochromocytoma subtypes.
Main Methods:
- Review of diagnostic modalities including plasma/urinary metanephrines, MRI, CT, and MIBG scintigraphy.
- Discussion of clinical presentation and diagnostic criteria.
- Overview of treatment options: surgery, chemotherapy, and radiotherapy.
Main Results:
- Plasma or urinary metanephrines demonstrate high sensitivity (~98%) for pheochromocytoma detection.
- Imaging techniques like MRI, CT, and MIBG scintigraphy aid in tumor localization.
- Surgical resection is the primary curative treatment, while other modalities are palliative for malignant cases.
Conclusions:
- Pheochromocytoma requires high clinical suspicion, especially in hypertensive patients or those with hypercatecholaminemia symptoms.
- Accurate diagnosis relies on biochemical testing and advanced imaging.
- Prompt surgical intervention offers the best prognosis; multimodal therapy is used for advanced disease.